Roth hires Eric Cheng to head healthcare investment banking

Roth Capital Partners named Eric Cheng as managing director, head of healthcare investment banking.

Mr. Cheng joins Roth from Maxim Group where he was senior managing director, head of healthcare investment banking. He has more than 20 years of investment banking experience and has completed more than 130 equity, debt and M&A transactions, representing over $8.5-billion in value. He has advised and raised capital for a wide range of biotechnology, specialty pharmaceutical, medical device and healthcare services companies.

“Eric’s extensive credentials in the healthcare sector will reinforce our firm’s expertise in capital transactions and advisory services for emerging companies in the industry,” said CEO, Byron Roth.

Mr. Cheng said he was delighted to begin this next phase of his career with Roth and join a prominent and highly regarded full service investment bank serving growth companies.

Sign up for the BioTuesdays weekly newsletter

Get the latest news on the healthcare industry’s corporate and clinical developments, executive moves, and market updates. Every Tuesday, in your inbox.